Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Danian Dai"'
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Estrogen receptor-positive and progesterone receptor-negative (ER + /PR-) breast cancer comprise a special type. More than 10% breast cancer patients belonged to ER + /PR-. Methods In order to better understand this patient popula
Externí odkaz:
https://doaj.org/article/d27ed53996544040ab8cae49f3751023
Publikováno v:
Heliyon, Vol 10, Iss 8, Pp e29326- (2024)
Objectives: The impact of N7-methylguanosine (m7G) on tumor progression and the regulatory role of microRNAs (miRNAs) in immune function significantly influence breast cancer (BC) prognosis. Investigating the interplay between m7G modification and mi
Externí odkaz:
https://doaj.org/article/939a863d71f94d70bd942041914fd1ae
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Most of the high-grade serous ovarian cancers (HGSOC) are accompanied by P53 mutations, which are related to the nucleotide excision repair (NER) pathway. This study aims to construct a risk signature based on NER-related genes that could effectively
Externí odkaz:
https://doaj.org/article/137dbd2534ed470ca2b4fb607cb2e579
Autor:
Danian Dai, Lili Liu, He Huang, Shangqiu Chen, Bo Chen, Junya Cao, Xiaolin Luo, Feng Wang, Rongzhen Luo, Jihong Liu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundTumor-infiltrating lymphocytes (TILs) have important roles in predicting tumor therapeutic responses and progression, however, the method of evaluating TILs is complicated. We attempted to explore the association of TILs with clinicopatholo
Externí odkaz:
https://doaj.org/article/21d5293972d04920ac4a6d31cd083a05
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: PARPBP (PARP1 binding protein) is an important suppressor of homologous recombination during DNA repair, but the expression and function of PARPBP in breast cancer remain unclear. Methods: PARPBP expression was analyzed in breast cancer p
Externí odkaz:
https://doaj.org/article/14b554c8d7a94d89b78b1662477518e3
Publikováno v:
World Journal of Surgical Oncology, Vol 15, Iss 1, Pp 1-8 (2017)
Abstract Background With limited sample sizes and single-institution designs, how complete response (CR) after neoadjuvant chemotherapy (NAC) influences breast conserving surgery (BCS) and its value in prognosis are not clear. Methods A systematic re
Externí odkaz:
https://doaj.org/article/1c1d52dc6fbc4968a6c4f7068f3c205e
Autor:
Bo Chen, Jin Wang, Danian Dai, Qingyu Zhou, Xiaofang Guo, Zhi Tian, Xiaojia Huang, Lu Yang, Hailin Tang, Xiaoming Xie
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 36, Iss 1, Pp 1-11 (2017)
Abstract Background AHNAK, also known as desmoyokin, is a giant protein with the molecular size of approximately 700 kDa and exerts diverse functions in different types of cancer. Results In the present study, we demonstrated that AHNAK mRNA levels w
Externí odkaz:
https://doaj.org/article/f0e55c1cb4d843e18351773d290e452b
Publikováno v:
PLoS ONE, Vol 13, Iss 2, p e0192464 (2018)
The phosphatidylinositol-3- kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway (PI3K/AKT/mTOR pathway) plays a key role in cancer. We performed this meta-analysis to assess the clinical effect of using PI3K/AKT/mTOR pathway inhibitors on
Externí odkaz:
https://doaj.org/article/52091407aeba4724b132159da88430a6
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0161902 (2016)
Previous studies have indicated that carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) levels are both independent prognostic factors in breast cancer. However, the utility of CEA and CA15-3 levels as conventional cancer biomarkers in p
Externí odkaz:
https://doaj.org/article/e23d9aa6bfdb437a9c2728a66a2a16ea
Autor:
Bo Chen, Danian Dai, Hailin Tang, Xiaohong Ai, Xi Chen, Xiaoyan Zhang, Zhiyan Li, Xiaoming Xie
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0165133 (2016)
Anemia usually refers to low hemoglobin (Hb) levels. Previous studies indicated that anemia negatively influence the survival in various cancers. Hematocrit (HCT) is the volume percentage of red blood cells in blood, which could indicate anemia in bo
Externí odkaz:
https://doaj.org/article/57b41b6465544a2ab0fc987443bbc332